Advisors Approve NCI Plan To Contract For Early Clinical Trials Of Imaging Agents.
NCI Recruits Carl Barrett Of NIEHS To Direct Basic Sciences; Freedman named to NCAB.
Sieber Direct Communications At NCI, Reorganizing Offices.
“5 A Day” Review Underway to Check Program’s Health at NCI.
AACR Honors Nine Cancer Researchers, Clinicians.
Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.
FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.
Bristol-Myers, Karolinska In Collaboration For Studies.
Antigenics Begins Phase II Trial Of Oncophage for NHL.
Aphton To Test Anti-Gastrin Drug At M. D. Anderson. NAS
RFP: Intellectual Property.
- Narjust Duma named associate director of the Cancer Care Equity Program at DFCI, Harvard Medical School
- Robert Stone: City of Hope aims to transform cancer care nationally through new models, partnerships
- Biden commits to creating “ARPA-H” research body in visit to Ohio State
- Amy Reed, physician and patient who “moved mountains” to end widespread use of power morcellation, dies at 44
- The Cancer Letter gets a new website
You may have noticed that things are looking different around here
- Abecma receives FDA approval for multiple myeloma